1. Muller F, Aukrust P, Svardal AM, et al. The thiols glutathione, cysteine, and homocysteine in human immunodeficiency virus (HIV) infection. In: Watson RR (Ed.). Nutrients and Foods in AIDS. 1st Edition. CRC Press. New York, New York. 1998:35-69.

2. Barbaro G, Di Lorenzo G, Soldini M, et al. Hepatic glutathione deficiency in chronic hepatitis C: quantitative evaluation in patients who are HIV positive and HIV negative and correlations with plasmatic and lymphocytic concentrations and with the activity of the liver disease. Am J Gastroenterol. 1996;91(12):2569-2573 .

3. Muller F, Aukrust P, Svardal AM, et al. Thiols to treat AIDS. In: Watson RR (Ed.). Nutrition and AIDS. 2nd Edition. CRC Press. New York, New York. 2001:84.

4. Herzenberg LA, De Rosa SC, Dubs JG, et al. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci USA. 1977;94(5):1967-1972.

5. Beloqui O, Prieto J, Suarez M, et al. N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study. J Interferon Res. 1993;13(4):279-282.

6. Kalayjian RC, Skowron G, Emgushov RT, et al. A phase I/II trial of intravenous L-2 oxothiazone-4-carboxylic acid (procysteine) in asymptomatic HIV-infected subjects. J Acquir Immune Defic Syndr. 1994;7(4):369-374.

7. Fuchs J, Schofer H, Milbradt R, et al. Studies on lipoate effects on blood redox state in human immunodeficiency virus infected patients. Arzneimittelforschung. 1993;43(12):1359-1362.

8. Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Rad Biol Med. 1995;19(2):227-250.

9. Kieburtz K, Schifitto G, McDermott M, et al. A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders. Neurology. 1998;50(3):645-651.

10. Jayanthi S, Varalakshmi P. Tissue lipids in experimental calcium oxalate lithiasis and the effect of DL alpha-lipoic acid. Biochem Int. 1992;26:913-921.

11. Vendemiale G, Altomare E, Trisio T, et al. Effects of oral S-adenosyl-L-methionine on hepatic glutahtione in patients with liver disease. Scand J Gastroenterol. 1989;24(4):407-415.

12. Castagna A, Le Grazie C, Accordini A, et al. Cerebrospinal fluid S-adenosylmethionine (SAMe) and glutathione concentrations in HIV infection: effect of parenteral treatment with SAMe. Neurology. 1995;45(9):1678-1683.

13. Beach RS, Mantero-Atienza E, Shor-Pozner G. et al. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS. 1992;6(7):701-708.

14. Dworkin BD, Wormser GP, Axelrod F, et al. Dietary intake in patients with acquired immunodeficiency syndrome (AIDS), patients with AIDS-related complex, and serologically postive human immunodeficiency virus patients: correlations with nutritional status. JPEN. 1990;14(6):605-609.

15. Abrams B, Duncan D, Hertz-Picciotto I. A prospective study of dietary intake and acquired immunodeficiency syndrome in HIV-seropositive homosexual men. J Acquir Immune Defic Syndr. 1993;6(8):949-958.

16. Ganser A, Greher J, Volkers B, et al. Azidothymidine in the treatment of AIDS. N Engl J Med. 1988;318(4):250-251.

17. Geissler RG, Ganser A, Ottmann OG, et al. In vitro improvement of bone marrow-derived hematopoetic colony formation in HIV-positive patients by alpha-D-tocopherol and erythropoetin. Eur J Haematol. 1994;53(4):201-206.

18. Baum MK, Shor-Posner G, Lai S, et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15(5):370-374.

19. Look MP, Rockstroh JK, Rao GS, et al. Serum selenium, plasma glutathione (GSH), and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodefiency virus-1 (HIV-1)-infection. Eur J Clin Nutr. 1997;51(4):266-272.

20. Delmas-Beauvieux MC, Peuchant E, Couchouron A, et al. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or beta-carotene. Am J Cl Nutr. 1996;64(1):101-107.

21. Olmstead L, Schrauzer GN, Flores-Arce M, et al. Selenium supplementation of symptomatic human immunodeficiency virus infected patients. Biol Trace Elem Res. 1989;29:59-65.

22. Shabert JK, Wilmore DW. Glutamine deficiency as a cause of human immunodeficiency virus wasting. Med Hypotheses. 1996;46(3):252-256.

23. Noyer CM, Simon D, Borczuk A, et al. A double-blind placebo-controlled pilot study of glutamine therapy for abnormal intestinal permeability in patients with AIDS. Am J Gastroenterol. 1998;93(6):972-975.

24. Clarke RH, Feleke G, Din M, et al. Nutritional treatment for acquired immune deficiency syndrome virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, placebo-controlled study. JPEN. 2000;24:133-139.

25. Shabert J, Winslow C, Lacey JM, Wilmore DW. Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: a randomized, double-blind controlled trial. Nutrition. 1999;15(11-12):860-864.

26. De Simone C, Tzantzoglou S, Jirillo E, et al. Carnitine deficiency in AIDS patients. AIDS. 1992;6(2):203-205.

27. Ibid

28. De Simone C, Famularo G, Tzantzoglou S, et al. Carnitine depletion in peripheral blood mononuclear cells from patients with AIDS: effect of oral L-carnitine. AIDS. 1994;8(5):655-660.

29. Kuratsune H, Yamaguti K, Lindh G, et al. Low levels of serum acylcarnitine in chronic fatigue syndrome and chronic hepatitis type C, but not seen in other diseases. Int J Mol Med. 1998;2(1):51-56.

30. De Simone C, Tzantzoglou S, Famularo G, et al. High-dose L-carnitine improves immunologic and metabolic parameters in AIDS patients. Immunopharmacol Immunotoxicol. 1993;15(1):1-12.

31. Campos Y, Huertas R, Lorenzo G, et al. Plasma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy. Muscle Nerve. 1993;16(2):150-153.

32. Dalakas MC, Leon-Monzon ME, Bernardini I, et al. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage. Ann Neurol. 1994;35(4):482-487.

33. Arnaudo E, Dalakas M, Shanske S, et al. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet. 1991;337(8740):508-510.

34. Davis HJ, Miene LJ, van der Westhuizen N, et al. L-carnitine and magnesium as a supportive supplement with antiviral drugs. Abstract 42384. Int Conf AIDS 1998;12:851.